Association between serum uric acid levels and clinical outcomes of immunotherapy in advanced colorectal cancer patients
Elevated baseline serum UA is associated with poorer long-term survival in patients with dMMR/MSI-H advanced colorectal cancer receiving immunotherapy. As an accessible and cost-effective biomarker, UA shows potential for early risk-stratification and guiding individualized treatment strategies within this immunotherapy-sensitive population.
Authors
- Mingchen Shao
- Sufeng Fan
- Wang Ma
Institutions
- Henan University (CN)
- Zhengzhou University (CN)
- Henan Provincial People's Hospital (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2026-01-03
- DOI
- https://doi.org/10.1186/s12885-025-15431-y
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 0.00